A single dose of a monoclonal antibody developed by scientists at the US National Institutes of Health (NIH) has provided protection for people exposed to malaria parasites for up to nine months.

Writing in Cell Reports, researchers from the National Institute of Allergy and Infectious Diseases (NIAID) and collaborators have presented a multifaceted analysis and structure-function study of a ...

The SARS-CoV-2 virus genome had barely been sequenced when there was a major effort to develop a safe and effective vaccine against it. But scientists working on COVID vaccines have one key thing ...